Convalescent Plasma Therapy in Immunocompromised Patients Infected With the BA.1 or BA.2 Omicron SARS-CoV-2

被引:0
作者
Richier, Quentin [1 ]
De Valence, Benjamin [1 ]
Chopin, Dorothee [1 ]
Gras, Emmanuelle [1 ,2 ]
Levi, Laura I. [1 ,2 ]
Aad, Yasmine Abi [1 ]
Pacanowski, Jerome [1 ]
Meynard, Jean-Luc [1 ]
Placais, Leo [3 ]
Fey, Dorothee [1 ]
Couture, Priscille [4 ]
Martin-Blondel, Guillaume [5 ,6 ,7 ]
Pestre, Vincent [8 ]
Woessner, Juliette [8 ]
Ancellin, Sophie [9 ]
Weyrich, Pierre [10 ]
Carpentier, Benjamin [10 ]
Idri, Salim [11 ]
Tiberghien, Pierre [12 ,13 ]
Surgers, Laure [1 ,2 ]
Hueso, Thomas [14 ]
Lacombe, Karine [1 ,2 ]
机构
[1] Hop St Antoine, AP HP, Serv Malad Infect, Paris, France
[2] Sorbonne Univ, Inserm UMR S1136, IPLESP, Paris, France
[3] Hop Bicetre, Dept Med Interne & Immunol Clin, Le Kremlin Bicetre, France
[4] Hop Foch, Serv Med Interne, Suresnes, France
[5] Ctr Hosp Univ Toulouse, Serv Malad Infect & Trop, F-31300 Toulouse, France
[6] Ctr Physiopathol Toulouse Purpan, INSERM UMR1043, Toulouse, France
[7] Univ Toulouse Paul Sabatier, Fac Med, Toulouse, France
[8] Ctr Hosp Avignon, Serv Med Interne & Malad Infect, Avignon, France
[9] Ctr Hosp Auch, Auch, France
[10] Grp Hop Catholiques Lille, Unite Infectiol, F-59160 Lille, France
[11] Etab Francais Sang, Creteil, France
[12] Etab Francais Sang, La Plaine St Denis, France
[13] UMR 1098 RIGHT Inserm Univ Franche Comte, Etab Francais Sang, Besancon, France
[14] Sorbonne Paris Nord Univ, Hop Avicenne, Serv Radiol, Serv Hematol Clin, Bobigny, France
关键词
convalescent plasma; COVID-19; immunocompromised; Omicron variant; SARS-CoV-2;
D O I
10.1111/irv.13272
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The emergence of SARS-CoV-2 Omicron variant has led to a complete reconfiguration of the therapeutic landscape, with all monoclonal antibodies having lost any neutralization activity. We report here a case series of 75 immunocompromised patients infected by the Omicron variant who benefited from COVID-19 convalescent plasma (CCP). At Day 28, the overall survival was 76% (95% CI 67-86) with no significant difference in the clinical outcome between patients with hematological malignancies, solid organ transplantation or autoimmune diseases. No safety concern was reported during the course of the study. These results showed that CCP is well tolerated and represents a treatment option for immunocompromised patients who remain highly impacted by the COVID19 epidemic.
引用
收藏
页数:5
相关论文
共 16 条
  • [1] Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients
    Baron, Frederic
    Canti, Lorenzo
    Arien, Kevin K.
    Kemlin, Delphine
    Desombere, Isabelle
    Gerbaux, Margaux
    Pannus, Pieter
    Beguin, Yves
    Marchant, Arnaud
    Humblet-Baron, Stephanie
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [2] Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report
    Blennow, Ola
    Salmanton-Garcia, Jon
    Nowak, Piotr
    Itri, Federico
    Van Doesum, Jaap
    Lopez-Garcia, Alberto
    Farina, Francesca
    Jaksic, Ozren
    Pinczes, Laszlo Imre
    Bilgin, Yavuz M.
    Falces-Romero, Iker
    Jimenez, Moraima
    Ormazabal-Velez, Irati
    Weinbergerova, Barbora
    Dulery, Remy
    Stojanoski, Zlate
    Lahmer, Tobias
    Fernandez, Noemi
    Hernandez-Rivas, Jose-angel
    Petzer, Verena
    De Jonge, Nick
    Glenthoj, Andreas
    De Ramon, Cristina
    Biernat, Monika M.
    Fracchiolla, Nicola
    Aujayeb, Avinash
    Van Praet, Jens
    Schonlein, Martin
    Mendez, Gustavo-Adolfo
    Cattaneo, Chiara
    Guidetti, Anna
    Sciume, Mariarita
    Ammatuna, Emanuele
    Cordoba, Raul
    Garcia-Pouton, Nicole
    Graefe, Stefanie
    Cabirta, Alba
    Wolf, Dominik
    Nordlander, Anna
    Garcia-Sanz, Ramon
    Delia, Mario
    Berg Venemyr, Caroline
    Brones, Clara
    Di Blasi, Roberta
    De Kort, Elizabeth
    Meers, Stef
    Lamure, Sylvain
    Serrano, Laura
    Merelli, Maria
    Coppola, Nicola
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (08) : E312 - E317
  • [3] Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
    Feng, Shuo
    Phillips, Daniel J.
    White, Thomas
    Sayal, Homesh
    Aley, Parvinder K.
    Bibi, Sagida
    Dold, Christina
    Fuskova, Michelle
    Gilbert, Sarah C.
    Hirsch, Ian
    Humphries, Holly E.
    Jepson, Brett
    Kelly, Elizabeth J.
    Plested, Emma
    Shoemaker, Kathryn
    Thomas, Kelly M.
    Vekemans, Johan
    Villafana, Tonya L.
    Lambe, Teresa
    Pollard, Andrew J.
    Voysey, Merryn
    [J]. NATURE MEDICINE, 2021, 27 (11) : 2032 - +
  • [4] Reduced neutralizing antibody potency of COVID-19 convalescent vaccinated plasma against SARS-CoV-2 Omicron variant
    Gallian, Pierre
    Amroun, Abdennour
    Laperche, Syria
    Le Cam, Sophie
    Brisbarre, Nadege
    Malard, Lucile
    Nurtop, Elif
    Isnard, Christine
    Richard, Pascale
    Morel, Pascal
    Tiberghien, Pierre
    de Lamballerie, Xavier
    [J]. VOX SANGUINIS, 2022, 117 (07) : 971 - 975
  • [5] Feasibility of Convalescent Plasma Therapy in Kidney Transplant Recipients With Severe COVID-19: A Single-Center Prospective Cohort Study
    Gupta, Akash
    Kute, Vivek B.
    Patel, Himanshu, V
    Engineer, Divyesh P.
    Banerjee, Subho
    Modi, Pranjal R.
    Rizvi, Syed J.
    Mishra, Vineet V.
    Patel, Ansy H.
    Navadiya, Vijay
    [J]. EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2021, 19 (04) : 304 - 309
  • [6] Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab
    Gupta, Anil
    Gonzalez-Rojas, Yaneicy
    Juarez, Erick
    Casal, Manuel Crespo
    Moya, Jaynier
    Falci, Diego R.
    Sarkis, Elias
    Solis, Joel
    Zheng, Hanzhe
    Scott, Nicola
    Cathcart, Andrea L.
    Hebner, Christy M.
    Sager, Jennifer
    Mogalian, Erik
    Tipple, Craig
    Peppercorn, Amanda
    Alexander, Elizabeth
    Pang, Phillip S.
    Free, Almena
    Brinson, Cynthia
    Aldinger, Melissa
    Shapiro, Adrienne E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (21) : 1941 - 1950
  • [7] Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis
    Hueso, Thomas
    Godron, Anne-Sophie
    Lanoy, Emilie
    Pacanowski, Jerome
    Levi, Laura, I
    Gras, Emmanuelle
    Surgers, Laure
    Guemriche, Amina
    Meynard, Jean-Luc
    Pirenne, France
    Idri, Salim
    Tiberghien, Pierre
    Morel, Pascal
    Besson, Caroline
    Dulery, Remy
    Lamure, Sylvain
    Hermine, Olivier
    Gagneux-Brunon, Amandine
    Freymond, Nathalie
    Grabar, Sophie
    Lacombe, Karine
    [J]. LEUKEMIA, 2022, 36 (04) : 1025 - 1034
  • [8] Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19
    Hueso, Thomas
    Pouderoux, Cecile
    Pere, Helene
    Beaumont, Anne-Lise
    Raillon, Laure-Anne
    Ader, Florence
    Chatenoud, Lucienne
    Eshagh, Deborah
    Szwebel, Tali-Anne
    Martinot, Martin
    Camou, Fabrice
    Crickx, Etienne
    Michel, Marc
    Mahevas, Matthieu
    Boutboul, David
    Azoulay, Elie
    Joseph, Adrien
    Hermine, Olivier
    Rouzaud, Claire
    Faguer, Stanislas
    Petua, Philippe
    Pommeret, Fanny
    Clerc, Sebastien
    Planquette, Benjamin
    Merabet, Fatiha
    London, Jonathan
    Zeller, Valerie
    Ghez, David
    Veyer, David
    Ouedrani, Amani
    Gallian, Pierre
    Pacanowski, Jerome
    Mekinian, Arsene
    Garnier, Marc
    Pirenne, France
    Tiberghien, Pierre
    Lacombe, Karine
    [J]. BLOOD, 2020, 136 (20) : 2290 - 2295
  • [9] Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency
    Lang-Meli, Julia
    Fuchs, Jonas
    Mathe, Philipp
    Ho, Hsi-en
    Kern, Lisa
    Jaki, Lena
    Rusignuolo, Giuseppe
    Mertins, Susanne
    Somogyi, Vivien
    Neumann-Haefelin, Christoph
    Trinkmann, Frederik
    Mueller, Michael
    Thimme, Robert
    Umhau, Markus
    Quinti, Isabella
    Wagner, Dirk
    Panning, Marcus
    Cunningham-Rundles, Charlotte
    Laubner, Katharina
    Warnatz, Klaus
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (02) : 253 - 265
  • [10] Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19
    Levin, Myron J.
    Ustianowski, Andrew
    De Wit, Stephane
    Launay, Odile
    Avila, Miles
    Templeton, Alison
    Yuan, Yuan
    Seegobin, Seth
    Ellery, Adam
    Levinson, Dennis J.
    Ambery, Philip
    Arends, Rosalinda H.
    Beavon, Rohini
    Dey, Kanika
    Garbes, Pedro
    Kelly, Elizabeth J.
    Koh, Gavin C. K. W.
    Near, Karen A.
    Padilla, Kelly W.
    Psachoulia, Konstantina
    Sharbaugh, Audrey
    Streicher, Katie
    Pangalos, Menelas N.
    Esser, Mark T.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (23) : 2188 - 2200